Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 151–200 of 344 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04758988	AI Augmented Training for Skin Specialists(AISC-SS)	completed	N/A	1,500	Herlev HospitalOTHER	1	Oct 16, 2024	clinicaltrials
NCT05615883	Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients(Agility)	completed	N/A	16	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Oct 15, 2024